Mylan boss calls for supplementary protection certificates manufacturing waiver

Generic drug manufacturers should be able to manufacture medicines that are within the scope of supplementary protection certificates (SPCs) for export to non-EU markets during the time that those SPCs apply, Mylan’s European president has said.